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Background: The World Health Organization recommends that all suspected malaria cases receive a parasitological
diagnosis prior to treatment with artemisinin-based combination therapy. A recent meta-analysis of clinical trials
evaluating RDTs for the management of patients with fever found substantial reductions in anti-malarial prescriptions
when health workers adhered to treatment protocols based on test results. However few studies have reported on the
impact of RDTs on health systems outside research settings.
Methods: The study comprised a retrospective interrupted time series analysis, comparing rates of malaria diagnosis,
treatment, and resource utilization before and after introduction of RDTs at a peripheral health facility in rural Western
Uganda. The use of malaria diagnostic tests was graphically depicted throughout the study period and fit regression
models to identify correlates of three outcomes of interest: (1) length of stay (2) the proportion of patients referred to a
higher-level health facility, and (3) administration of antibiotics.
Results: Over the course of the study period, 14,357 individuals underwent diagnostic testing for malaria with either a
RDT (9,807) or microscopy (4,550). The proportion of patients with parasite-based diagnoses more than tripled to 34 %
after the introduction of RDTs. RDTs largely replaced microscopy as the diagnostic method of choice. Compared
to patients admitted during the pre-RDT period, patients admitted to the health centre with malaria in the post-RDT
period had significantly reduced odds of being referred to another health centre (AOR = 0.49, P = 0.038), receiving
antibiotics (AOR = 0.42, P < 0.001), and a significantly shorter mean length of stay (β = −0.32 days, 95 %CI −0.52 to −0.13).
Conclusions: This study is one of the few to demonstrate significant improvement in clinical outcomes and process
measures following the introduction of RDTs for the diagnosis of malaria at a rural health facility in Uganda. The results
show a reduction in referrals and shorter mean inpatient LOS even as antibiotics were prescribed less frequently.
This change greatly increased laboratory throughput and the resultant proportion of patients receiving a parasite-based
diagnosis.
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Since 2010, the World Health Organization (WHO)
has recommended that all suspected malaria cases re-
ceive a parasitological diagnosis, either by microscopy
or a rapid diagnostic test (RDT), prior to treatment
with artemisinin-based combination therapy (ACT) [1].
Light microscopy is the traditional reference standard for
the diagnosis of malaria [1]. However, the vast majority of
malaria episodes occur in rural areas of sub-Saharan
Africa, where microscopy is often unavailable and
shortages of trained personnel further limit its use as a
valid diagnostic method [2–10]. Immunochromatographic
RDTs are low-cost, simple tools for the diagnosis of
malaria. In contrast to microscopy, RDTs require minimal
infrastructure, can by used by non-professional healthcare
staff, and provide a timely result [11].
A recent Cochrane Review of clinical trials evaluating
RDTs for the management of patients with fever found
substantial reductions in anti-malarial prescriptions when
health workers adhered to treatment protocols based on
test results [12]. However, the included studies demon-
strated significant heterogeneity in clinical outcomes, both
across and within a variety of study settings. The authors
concluded that while the introduction of RDTs did not
clearly improve health outcomes, adherence to the test
result did not seem to result in worse outcomes than
presumptive treatment strategies.
Few studies have reported on the impact of RDTs on
health systems outside research settings, leading some to
suggest that the existing evidence is insufficient to
abandon other diagnostic modalities [13]. The study
team attempted to address this knowledge gap through
a retrospective investigation of clinical data before and
after implementation of routine RDT availability at a
peripheral health centre in rural Uganda. The working
hypothesis was that the implementation of RDTs would
increase the proportion of patients with a parasite-
based diagnosis of malaria compared to microscopy
alone, leading to more accurate and timely clinical case
management and improved resource stewardship.
Methods
Study site
The Bugoye Level III Health Centre (BHC), in the Kasese
District of Western Uganda (0° 18′ North, 30° 5′ East)
functions as the referral centre for the Bugoye sub-county,
serving a rural population of approximately 50,000 res-
idents. The health centre is staffed by clinical officers,
nurses, midwives, and laboratory technicians from the
Ugandan Ministry of Health. The health centre is com-
posed of an outpatient clinic that attends to approximately
60 patients per day, a 20-bed inpatient ward and a 10-bed
maternity ward. A limited formulary of intravenous fluids,
antibiotics, and anti-malarials, including oral artemether-lumafantrine and intravenous quinine, is available. The
health centre houses a small laboratory with staff trained
to perform light microscopy, as well other basic tests, such
as hemoglobin estimation and rapid-HIV tests. The cli-
mate in Bugoye permits stable, year-round malaria trans-
mission, with test positivity rates that can reach upwards
of 50 % (unpublished data). RDTs were first introduced at
BHC in the summer of 2011, although monthly supplies
were initially highly variable.
Study design
The study was a retrospective interrupted time series,
comparing rates of malaria diagnosis, treatment, and re-
source utilization before and after introduction of RDT.
The timeframe of September 2010 to April 2014 was
sub-divided into three periods: (1) the period prior to
the introduction of RDTs when microscopy was the only
method of malaria diagnosis available (pre-RDT period),
(2) the 20 months following the introduction of RDTs
but when their availability remained inconsistent (transi-
tion period), and (3) the period after March 2013, when a
regular supply of RDT tests was available (RDT period).
The transition period was included to account for the time
required to assure a stable supply of test equipment,
adherence to diagnostic and treatment algorithms, and
appropriate use of the RDT under field conditions [12].
Six months of high transmission intensity were se-
lected in each period from which to abstract clinical and
programmatic information. In order to maximize the
sample size and limit the seasonal effect of malaria
transmission on the analysis, the months of October
through January and May through June when transmis-
sion is traditionally intense were included in the analysis.
Information on monthly malaria diagnostic test use during
the study period was collected from monthly Health Man-
agement Information System (HMIS) reports, which are
government-mandated documents completed for all
encounters at each public health facility.
In addition, the following data was abstracted from
clinical records for all inpatients with a discharge
diagnosis of malaria: age, gender, village of residence,
co-morbid diagnoses, type and route of anti-malarials
received, antibiotics received, length of stay, and discharge
disposition. The analysis was limited to inpatients with a
diagnosis of malaria because these records are generally
more accurate and complete than similar outpatient regis-
tries at the study site.
Statistical analysis
Data were entered into Microsoft Excel (Redmond, WA)
and analysed with Stata 12.1 (College Station, TX). The
use of malaria diagnostic tests was first graphically
depicted throughout the study period in order assess for
trends in RDT implementation. Patient characteristics
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using the ANOVA test.
The statistical analysis was designed to identify corre-
lates of three outcomes of interest: (1) length of hospital
stay (LOS) in days for patients who improved and were
subsequently discharged home, (2) proportion of pa-
tients referred to a higher-level health facility, and (3)
administration of antibiotics in patients with a discharge
diagnosis of malaria. The first two outcomes were
chosen as surrogate indicators of effective therapy for
malaria. Firsthand experience at the clinical site suggests
that patients who demonstrate improvement are dis-
charged home, and a shorter length of stay represents
the appropriate administration of anti-malarial therapy.
Conversely, those who do not improve with treatment
are referred to the regional referral hospital. Antibiotic
use was chosen as the third outcome of interest in order
to investigate whether implementation of RDTs would
decrease antibiotic use in patients with a diagnosis of
malaria. Logistical regression models were utilized in the
analysis of the two discrete outcomes (referral, antibiotic
use), while a linear regression model was used for the
LOS analysis.
The primary explanatory variable of interest was the
time period (pre-RDT, transition, and post-RDT). Second-
ary variables included gender, age (divided as <5, 5–15,
and >15 years old), access to care, presence of a comorbid
diagnosis, and transmission season defined as high (May-
Jul and Nov-Jan) or low (Feb-Apr and Aug-Oct). As a sur-
rogate of access to care, a remote village was defined as
one from which transportation costs typically exceed
5,000 Uganda Shillings (approximately $2USD), versusFig. 1 Trends in the use of malaria diagnostic tests (9/10–4/14)villages physically bordering the health centre, from where
most patients walk to the facility and do not incur costs of
transportation. Multivariable regression models including
all variables that were significant in univariable models
with a pre-specified p-value of <0.25 were then under-
taken [14]. A resulting p-value of <0.05 was considered
statistically significant in the final models.
Ethics statement
Ethical approval of the study was provided by the insti-
tutional review boards of Partners Healthcare and the
Mbarara University of Science and Technology. In-
formed consent was not required by the ethical review
committees due to the programmatic nature of the data
collection and retrospective review of data.
Results
RDT supply and utilization
Over the course of the study period, 14,357 individuals
underwent diagnostic testing for malaria with either a
RDT (9,807) or microscopy (4,550). Trends in the use of
these tests during the observation period are shown in
Fig. 1. There were no RDTs available in the pre-RDT
period. The supply of RDTs was unstable in the transi-
tion period, with five months of complete stock-outs
and four months of relative stock-outs. The majority
(73 %) of RDTs were performed over the final 14 months
of the study, when the supply became more consistent.
Figure 1 also highlights that the number of blood
smears performed was inversely related to the number
of RDTs performed. This is most clearly seen over the
last six months of the transition period and throughout
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and as a result, very few smears were performed.
While nearly 3,000 RDTs were performed at the health
centre during the transition period, the proportion of
patients with a diagnosis of malaria who received a
parasite-based diagnosis increased only slightly, from
7.5 % to 9.4 %. The average number of total diagnostic
tests, including both RDTs and microscopy, increased
from only 180 per month in the pre-RDT period to 223
per month in the transition period. In contrast, the pro-
portion of patients with parasite-based diagnoses more
than tripled to 34 % during the RDT period with the
proportion in the latter months consistently greater than
40 %. Over the same time period, the total number of
diagnostic tests exceeds 500 tests per month for the first
time and generally remained above that level.
Impact of RDT implementation on clinical care
Over the 18 months of analysis, with six high transmis-
sion months from each period, a total of 1,106 patients
were admitted to the ward and discharged with a diag-
nosis of malaria. Patient characteristics are summarized
in Table 1.
The proportion of patients < five years of age decreased
significantly from 52.3 to 41.2 % of the total patient
population, whereas there was a corresponding increase
in patients between the ages of five and 15 (p = 0.003).
The most common comorbidities among admitted patientsTable 1 Characteristics of inpatients with a diagnosis of malaria in d
Pre-RDT
Patients (n, % of admissions) 300 (80.4)
Male Patients (n, %) 125 (42.2)
Age (median, IQR) 4 (1.25, 16)
<5 years 157 (52.3)
5–15 years 57 (19.0)
>15 years 86 (28.67)
Village (n, %)
Bordering Villages 76 (26.6)
Remote Villages 46 (16.0)
Comorbid diagnosis (n, %)





Oral only 35 (11.7)
Antibiotics 225 (75.0)
LOS (mean, SD) 2.8 (1.3)
Referred (n, %) 21 (8.0 %)were respiratory tract infections and/or pneumonia
(28.4 %), diarrhoea and/or gastroenteritis (4.7 %), and
HIV (1.5 %). The proportion of admitted patients with
a documented comorbid diagnosis declined significantly
(p < 0.001) in the RDT period with most of the decline at-
tributable to a decrease in respiratory illnesses.
The majority (65.3 %) of patients admitted with a diag-
nosis of malaria received antibiotics, but the proportion
decreased during the observation period, from 75.0 to
53.6 % from the pre- to post-RDT periods (p < 0.001).
Similarly, the mean LOS decreased from 2.8 days (SD =
1.3) to 2.4 days (SD = 1.0, p < 0.001) and the proportion
of patients referred to another health centre decreased
from 7.4 to 4.2 % p = 0.086). These associations persisted
in multivariable regression models (Tables 2, 3 and 4).
Compared to patients admitted during the pre-RDT
period, patients admitted to the health centre with malaria
in the post-RDT period had significantly reduced odds of
being referred to another health centre (AOR = 0.49, p =
0.038), receiving antibiotics (AOR = 0.42, p < 0.001), and a
significantly shorter mean length of stay (β = −0.32,
95 %CI −0.52 to −0.13, p = 0.001), corresponding to a
shorter mean hospital duration of stay by 0.32 days (ap-
proximately 8 hours) in the post-RDT period.
Discussion
These results demonstrate significant decreases in inpatient
LOS, referrals to higher-level facilities, and antibioticefined study periods
Transition Post-RDT P-value
282 (72.7) 524 (69.3) 0.33
119 (42.5) 231 (44.3) 0.8
9 (2.1, 21) 7 (3, 18) 0.27
111 (39.36) 216 (41.2) 0.003
57 (20.2) 148 (28.2)
114 (40.43) 160 (30.5)
90 (33.1) 167 (33.2) 0.12
39 (14.6) 38 (7.9) <0.001
153 (54.3) 144 (27.5) <0.001
116 (41.1) 94 (17.9) <0.001
12 (4.3) 19 (3.6) 0.08
260 (92.2) 486 (93.1) 0.024
19 (86.7) 33 (6.3) 0.012
216 (76.6) 279 (53.6) <0.001
2.5 (1.2) 2.4 (1.0) <0.001
12 (4.5 %) 16 (4.2 %) 0.086
Table 2 Correlates of antibiotic administration for patients with
a diagnosis of malaria
Univariable model Multivariable model*
OR 95 % CI P-value AOR 95 % CI P-value
Male sex 1.24 0.97–1.6 0.09 1.24 0.94–1.63 0.12
Age
>15 REF REF
5–15 0.98 0.71–1.35 0.88 - - -
<5 1.82 1.36–2.44 <0.001 1.97 1.44–2.70 <0.001
Remote 2.05 1.31–3.21 0.002 1.90 1.19–3.05 0.007
Referred 0.78 0.43–1.42 0.42 - - -
Period
Pre-RDT REF REF
Transition 1.09 0.75–1.60 0.65 - - -
RDT 0.38 0.28–0.53 <0.001 0.42 0.30–0.59 <0.001
RDT rapid diagnostic test, OR Odds ratio; *Explanatory variables with a P-value
of <0.25 in the univariable model were included in the multivariable model
Table 4 Correlates of referral for patients admitted with a
diagnosis of malaria
Univariable model Multivariable model*
OR 95 % CI P-value AOR 95 % CI P-value
Male sex 1.52 0.85–2.71 0.15 1.56 0.88–2.29 0.13
Age
>15 REF - - -
5–15 1.53 0.72–3.30 0.27 - - -
<5 1.13 0.57–2.26 0.73 - - -
Remote 1.27 0.55–2.92 0.57 - - -
Antibiotic 0.78 0.43–1.42 0.42 - - -
Period
Pre-RDT REF REF
Transition 0.55 0.26–1.13 0.11 0.54 0.26–1.12 0.099
RDT 0.51 0.26–0.99 0.046 0.49 0.25–0.96 0.038
*Explanatory variables with a P-value of <0.25 in the univariable model were
included in the multivariable model
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health facility in Western Uganda with a diagnosis of
malaria following the implementation of RDTs. Taken
together, these findings suggest an improvement in
clinical outcomes and health system resource alloca-
tion. This study, while retrospective, is among the first
to detect a significant improvement in clinical out-
comes attributable to the introduction of RDTs.
Notably, it was not until the RDT period, when the
supply of diagnostic tests was more reliable, that a statis-
tically significant decreases in the rates of antibiotic ad-
ministration and referral was observed. This relationship
further supports the hypothesis that the implementation
of RDTs can improve the effectiveness of care delivery.
The trend also suggests that much of the observed effect of
RDTs may not be attributable to better test performance,Table 3 Correlates of length of hospital stay (in days) for patients ad
Univariable model
β 95 % CI P-v
Male sex 0.05 −0.11–0.21 0.5
Age
>15 REF
5–15 −0.17 −0.38–0.44 0.1
<5 0.01 −0.17–0.19 0.9
Remote 0.36 0.10–0.61 0.
Antibiotics 0.23 0.07–0.40 0.
Period
Pre-RDT REF
Transition −0.26 −0.46 to −0.06 0.
RDT −0.38 −0.56 to −0.19 <0
RDT rapid diagnostic test, OR Odds ratio; *Explanatory variables with a P-value of <but rather to the increase in laboratory capacity. These re-
sults suggest that a change to RDTs as the primary method
of malaria diagnosis resulted in two- to three-fold increase
in laboratory throughput, with a similar increase in the pro-
portion of patients with a parasite-based diagnosis.
As the proportion of patients with a parasitologically
confirmed diagnoses increased, there was a correspond-
ing decrease in presumptive diagnosis and treatment,
often referred to as “clinical malaria.” Health workers at
the study site reported that they felt more certain about
the diagnosis in patients with positive RDTs and thus
did not list alternate etiologies, such as co-morbid re-
spiratory tract infections or gastroenteritis, symptoms of
which can be common with malaria infections [15, 16].
Health workers also commented that with greater confi-
dence in the diagnosis, they were less likely to prescribemitted with a diagnosis of malaria
Multivariable model*
alue β 95 % CI P-value
4 - - -
REF
2 −0.12 −0.34–0.10 0.29
1 - - -
006 0.27 0.02–0.53 0.033
006 0.17 −0.01–0.35 0.058
REF
011 −0.26 −0.46 to −0.05 0.015
.001 −0.32 −0.52 to −0.13 0.001
0.25 in the univariable model were included in the multivariable model
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ment with similar decrease in both co-morbid diagnoses
and antibiotic prescriptions over the study period.
While these findings are intriguing, the near abandon-
ment of microscopy merits further assessment. A shift to
RDTs as the primary means of malaria diagnosis, as seen in
other studies [17], raises concerns about the maintenance
of critical laboratory proficiency. Microscopy offers the
advantages of malaria species identification and estimates
of parasite density. The poor quality of routine microscopy
at many peripheral health centres likely over-estimates this
limitation [2–4, 18] and preliminary work suggests that
RDTs may be able to provide some quantitative esti-
mate of parasite density [19–21]. Additionally, in areas
of P. falciparum predominance, such as Uganda [22],
the clinical utility of species identification is limited.
The study does have a number of methodological limi-
tations. First, the study was ecological in design and thus
assumes that the changes observed over the three de-
fined periods were primarily attributable to the intro-
duction of RDTs rather than other unmeasured factors.
One will note there was a large increase in the number
of admitted patients in the RDT period. This may be
due to severe flooding that cut off nearby local villages
from other health centres. It is reassuring, however, that
the proportion of patients admitted with a diagnosis of
malaria was not significantly different (80 % vs. 69 %,
p = 0.33). Moreover, the consistent effect of RDTs,
similar to a dose–response relationship, seen across the
three study periods also partially mitigates this concern.
Second, HMIS reports and inpatient registries served
as a primary data source for the analysis. These records
are often incomplete and/or of variable accuracy, and
thus could bias the above estimates. However, there is
no reason to believe that the completeness or accuracy
of the records changed over time, which would cause a
differential effect by study period. The study team
attempted to minimize this source of bias in three main
ways. First, the team reviewed all data during the period
of analysis and found no missing period or data points
in the HMIS reports, and no evidence of suspicious
entries, such as multiple months with identical values.
Second, every effort was made to validate these
results, including cross-referencing different sources
such as laboratory records. Lastly, and most important,
clinical information about individual patient diagnoses,
treatment, and disposition was abstracted directly
from the inpatient registrars. In the author’s experi-
ence in Bugoye, these records are generally of higher
quality, which was one of the primary reasons for
using this dataset as the basis for the analysis. For the
three specified outcomes of interest, the individual
data was available from clinical registries for greater
than 80 % of admitted patients.Third, while the study suggests improved clinical out-
comes and a reduction in antibiotic administration in
admitted patients with a diagnosis of malaria, it did not
examine the impact on patients without a documented
diagnosis of malaria or those with negative RDT results.
Despite these limitations, this natural experiment pro-
vides a unique look at the relationship between supply,
capacity, diagnoses, and clinical outcomes. In fact, one
of the strengths of the study is that there was no additional
study-related training, monitoring, or funding. This char-
acteristic enables consideration of these data as a real-
world assessment of the implementation of RDTs, and
augments the generalizability to other non-experimental
clinical sites in rural Africa.
Conclusions
This study is one of the few to demonstrate significant
improvement in clinical outcomes and process measures
following the introduction of RDTs for the diagnosis of
malaria at a rural health facility in Uganda. The results
demonstrate a significant reduction in referrals and shorter
mean inpatient LOS even as antibiotics were prescribed less
frequently. RDTs essentially replaced microscopy as the
diagnostic method of choice. This change greatly increased
laboratory throughput and the resultant proportion of pa-
tients receiving a parasite-based diagnosis. Future studies
should evaluate the wider implications of a RDT-based
strategy before further definitive policy change can be
recommended.
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